2025. Comparing The Safety And Efficacy Of Sitagliptin Vs Dapagliflozin And The Risk Of Hyperkalaemia Among People With Type 2 Diabetes Mellitus And Kidney Disease . Vascular and Endovascular Review. 8, 9s (Nov. 2025), 230–236. DOI:https://doi.org/10.64149/J.Ver.8.9s.230-236.